Small animal imaging process involves usage of imaging devices and reagents for the monitoring of cellular and molecular processes for different applications. These applications include diagnostic, therapeutic, biological, and biochemical applications in animals like mice and rats for drug development and gene expression studies. The global small animal imaging market is anticipated to emerge as a prominent market over the forecast period, as per the latest analysis by Market Research Future (MRFR). The global small animal imaging market is anticipated to expand at a 6.5% CAGR during the forecast period of 2018-2023.

Owing to the wide scope of application in different fields of study, the small animal imaging market is upscaling at a high rate. Further, the small animal imaging systems are cost-effective for regular validation and commercialization of new drugs as it includes a full-body scan of the animal. Proliferated technological advancements and development of various non-invasive small animal imaging techniques are expected to push favorable growth in the global small animal imaging market over the forecast period.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6175

Moreover, key players in the small animal imaging market are observed to focus on the continuous launches of advanced and differentiated products to diversify their product portfolio and aid them to gain a higher competitive advantage over their rivals. This is anticipated to fuel sizeable growth in the global small animal imaging market.

Key Players

Some of the noteworthy vendors in the global small animal imaging market include PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.), and Miltenyi Biotec GmbH (Germany).

Market Segmentation

The global small animal imaging market is studied for various segments based on modality and reagents.

Based on modality, the market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-CT systems, micro-ultrasound systems, magnetic particle imaging (MPI) systems, and photoacoustic imaging systems.
Based on reagents, the global small animal imaging market is segmented into optical imaging reagents, nuclear imaging reagents, ultrasound contrast agents, MRI contrast agents, and CT contrast agents. The optical imaging reagents segment is further sub-segmented into bioluminescent imaging reagents and fluorescent imaging reagents. The nuclear imaging reagents segment is further segmented into pet tracers and spect probes. The MRI contrast agents segment is sub-segmented into gadolinium-based small animal contrast agents, manganese-based small animal contrast agents, and iron-based animal contrast agents. The CT contrast agents segment is sub-segmented into barium-based small animal CT contrast agents, iodine-based small animal CT contrast agents, gastrografin-based small animal CT contrast agents, and gold nanoparticles.
Detailed Regional Analysis

The global small animal imaging market is studied for the regional segments of the Americas, Europe, Asia Pacific, and the Middle East & Africa. The small animal imaging market in the Americas is sub-segmented into North America and South America. Among these regions, the Americas are anticipated to spearhead the global small animal imaging market over the assessment period. Such market dominion can be accredited to the mounting investments by clinical research organizations in pre-clinical studies, increasing government funding to encourage higher research activities. Further, a rise in the number of pharmaceutical and research-based organizations are anticipated to drive the regional small animal imaging market.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/small-animal-imaging-market-6175

Europe is anticipated to witness significant growth during the forecast period. This is attributable to the increasing investments in the research and development activities by pharmaceutical companies and a growing number of research organizations for the diagnosis of diseases. Europe is expected to capture the second-largest share in the global small animal imaging market by the end of the review period.

Asia Pacific is anticipated to surge at the fastest rate owing to the increasing government support for the development of the biotechnology and pharmaceutical sector. Further, growing number of translational research activities are anticipated to push favorable growth in the regional small animal imaging market.

The Middle East & Africa is expected to showcase the lowest rate of growth for the small animal imaging market. This can be owed to a lack of awareness and poor government support for the development of the healthcare sector.